BRANDON MOREHEAD: Open Payments
NPI 1063088300 · PADUCAH, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,040 in 176 payments from 20 companies in 2025. Trend: 2023 $780 · 2024 $1,280 · 2025 $3,040
Food & beverage: $2,910Consulting: $115Education: $15
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 36 | $513 |
| Teva Pharmaceuticals USA, Inc. | 13 | $437 |
| Otsuka America Pharmaceutical, Inc. | 17 | $339 |
| Supernus Pharmaceuticals, Inc. | 16 | $311 |
| ABBVIE INC. | 25 | $218 |
| Alkermes, Inc. | 12 | $189 |
| Vanda Pharmaceuticals Inc. | 10 | $155 |
| E.R. Squibb & Sons, L.L.C. | 12 | $138 |
| Janssen Pharmaceuticals, Inc | 9 | $126 |
| Janssen Scientific Affairs, LLC | 1 | $115 |
Products named: CAPLYTA, Qelbree, AUSTEDO XR, SPRAVATO, REXULTI, VRAYLAR, UZEDY, COBENFY.
Industry payments across KY — which companies pay providers there.
